毕彦伟, 张思远, 格日勒. 2010-2018年内蒙古自治区锡林郭勒盟人间布鲁氏菌病防控效果分析[J]. 疾病监测, 2019, 34(12): 1064-1067. DOI: 10.3784/j.issn.1003-9961.2019.12.007
引用本文: 毕彦伟, 张思远, 格日勒. 2010-2018年内蒙古自治区锡林郭勒盟人间布鲁氏菌病防控效果分析[J]. 疾病监测, 2019, 34(12): 1064-1067. DOI: 10.3784/j.issn.1003-9961.2019.12.007
Yanwei Bi, Siyuan Zhang, Rile Ge. Performance of human brucellosis control in Xilingol league, Inner Mongolia, 2010–2018[J]. Disease Surveillance, 2019, 34(12): 1064-1067. DOI: 10.3784/j.issn.1003-9961.2019.12.007
Citation: Yanwei Bi, Siyuan Zhang, Rile Ge. Performance of human brucellosis control in Xilingol league, Inner Mongolia, 2010–2018[J]. Disease Surveillance, 2019, 34(12): 1064-1067. DOI: 10.3784/j.issn.1003-9961.2019.12.007

2010-2018年内蒙古自治区锡林郭勒盟人间布鲁氏菌病防控效果分析

Performance of human brucellosis control in Xilingol league, Inner Mongolia, 2010–2018

  • 摘要:
    目的通过分析2010 — 2018年内蒙古自治区锡林郭勒盟人间布鲁氏菌病(布病)防控工作,为布病防控工作提供参考依据。
    方法收集2010 — 2018年内蒙古自治区锡林郭勒盟人间布病报告病例。 通过年报告发病率评价疫情水平,血检阳性率和布病检出率评价高危人群的感染情况和发病情况,专业人员培训率、高危人群知识知晓率分别评价专业人员培训和高危人群健康教育活动的效果,规范治疗率和治愈率评价患者治疗管理工作效果。
    结果2010 — 2018年锡林郭勒盟共主动筛查布病高危人群198 915例,阳性8 434例,阳性率4.24%,发现新发病例2 319例,布病检出率1.17%;各年度主动调查发现的新发病例占网络报告数的比例差异有统计学意义(χ2=574.878,P<0.001);高危人群主动调查血检阳性率、布病检出率以及网络报告发病率均呈下降趋势(χ2=1 520.332、2 654.121和4 665.313,均P<0.001);高危人群布病防治知晓率由69.04%上升至90.83%;各年度布病专业技术人员技能考核达标率均高于98%。 2010 — 2013年病例治愈率较低,最低为52.78%,失访率高于30%;2014 — 2018年治愈率超过75%,失访率降至10%左右。
    结论锡林郭勒盟布病防控措施成效显著,但防控形势依然严峻,需继续加强防控,保证各项措施落实到位。

     

    Abstract:
    ObjectivesTo evaluate the performance of human brucellosis prevention and control in Xilingol league of Inner Mongolia from 2010 to 2018 and provide evidence for the local brucellosis prevention and control in the future.
    MethodsThe incidence data of human brucellosis in Xilingol from 2010 to 2018 were collected to analyze the incidence level. The infection status and morbidity of brucellosis in population at high risk were evaluated by using blood test positive rate and brucellosis detection rate, the effects of occupational training and health education were evaluated respectively by using the professional training rate in medical staff and the awareness rate of brucellosis related knowledge in population at high risk, and the effects of patient treatment and management were evaluated by using standardized treatment rate and cure rate.
    ResultsDuring 2010–2018, a total of 198 915 blood samples were tested in population at high risk, in which 8 434 were positive (4.24%), and 2 319 new brucellosis cases were detected (1.17%). There were significant differences in annual proportion of new cases detected in active investigation in cases reported through network (χ2=574.878, P<0.001). The positive rate, case detection rate of active investigation and the incidence rate reported through network in population at high risk showed decline trends (χ2=1 520.332, 2 654.121, and 4 665.313, P<0.001). The awareness rate of brucellosis in population at high risk increased from 69.04% to 90.83%. The annual qualified rates of medical staff engaged in brucellosis prevention and control in professional training were all higher than 98%. During 2010–2013, the cure rate of patients was low, the lowest was 52.78%, and the rate of follow up loss was higher than 30%. During 2014–2018, the cure rate was over 75%, and the rate of follow up loss dropped to about 10%.
    ConclusionThe prevention and control of brucellosis has made achievement in Xilingol, however, it remains challengeable. It is still necessary to strengthen the prevention and control of brucellosis by fully implementation of all the measures.

     

/

返回文章
返回